Finance

Lists
Q3 2026 earnings • released • EPS miss -17,39%
See results
NKTX:NASDAQ
Nkarta Inc
USD 1,73
+10,19%
(+0,16) 1D
USD 1,87
+8,09% (+0,14)
After hours
Closed: 6 Nov., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTX...
Open
USD 1,61
High
USD 1,84
Low
USD 1,61
Mkt. cap
123,91 m
Avg. vol.
1,00 m
Volume
2,11 m
52-wk high
USD 3,72
52-wk low
USD 1,48
EPS
-USD 1,58
Beta
1,24
Shares outstanding
71,62 m
No. of employees
106
Open
USD 1,61
High
USD 1,84
Low
USD 1,61
Mkt. cap
123,91 m
Avg. vol.
1,00 m
Volume
2,11 m
52-wk high
USD 3,72
52-wk low
USD 1,48
EPS
-USD 1,58
Beta
1,24
Shares outstanding
71,62 m
No. of employees
106
News stories
From web sources and news partners
About Nkarta Inc
CEO-
Employees106
Founded2015
HeadquartersSouth San Francisco, Kalifornië, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitenkartatx.com
Analyst ratings
Based on 5 analysts giving stock ratings to NKTX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NKTX in the last 3 months.
Highest
Current USD 1,73
USD 12,00 (+593,64%)
Average
USD 11,25 (+550,29%)
Lowest
USD 10,00 (+478,03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stephen Willey
Stifel Nicolaus
Buy
Reiterated
USD 10,00
+478%
11/06/2026
Emily Bodnar
H.C. Wainwright
Buy
Initiated
USD 12,00
+593,6%
11/02/2026
Gil Blum
Needham
Buy
Maintained
USD 11,00
+535,8%
10/05/2026
Salim Syed
Mizuho Securities
Buy
Maintained
USD 12,00
+593,6%
08/17/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/10/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
USD 9,00
+420,2%
05/18/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
03/26/2026
Last report
05 Nov. 2026
Fiscal period
Q3 2026
-USD 0,45 / -USD 0,38
-17,39%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20,20 m
25,28 m
24,99 m
29,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,30 m
5,31 m
5,89 m
6,03 m
Operating expense
26,50 m
30,59 m
30,88 m
35,08 m
Total operating expenses
26,50 m
30,59 m
30,88 m
35,08 m
Operating income
-26,50 m
-30,59 m
-30,88 m
-35,08 m
Other non operating income
1,72 m
162,00 k
206,00 k
222,00 k
EBT including unusual items
-21,72 m
-27,41 m
-27,83 m
-40,37 m
EBT excluding unusual items
-20,92 m
-27,14 m
-27,83 m
-32,32 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21,72 m
-27,41 m
-27,83 m
-40,37 m
Net profit margin
-
-
-
-
Earnings per share
-0,29
-0,37
-0,37
-0,54
Interest and investment income
3,85 m
3,30 m
2,84 m
2,54 m
Interest expense
-
-
-
-
Net interest expenses
3,85 m
3,30 m
2,84 m
2,54 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-24,19 m
-28,34 m
-28,54 m
-32,35 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme